{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T16:56:35Z","timestamp":1775321795604,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"am","delay-in-days":173,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","award":["NWN\/006\/025\/A"],"award-info":[{"award-number":["NWN\/006\/025\/A"]}],"id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Rheumatology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/s2665-9913(23)00003-6","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T09:14:14Z","timestamp":1674638054000},"page":"e67-e76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial"],"prefix":"10.1016","volume":"5","author":[{"given":"Andrew L","family":"Mammen","sequence":"first","affiliation":[]},{"given":"Anthony A","family":"Amato","sequence":"additional","affiliation":[]},{"given":"Mazen M","family":"Dimachkie","sequence":"additional","affiliation":[]},{"given":"Hector","family":"Chinoy","sequence":"additional","affiliation":[]},{"given":"Yessar","family":"Hussain","sequence":"additional","affiliation":[]},{"given":"James B","family":"Lilleker","sequence":"additional","affiliation":[]},{"given":"Iago","family":"Pinal-Fernandez","sequence":"additional","affiliation":[]},{"given":"Yves","family":"Allenbach","sequence":"additional","affiliation":[]},{"given":"Babak","family":"Boroojerdi","sequence":"additional","affiliation":[]},{"given":"Mark","family":"Vanderkelen","sequence":"additional","affiliation":[]},{"given":"Eumorphia Maria","family":"Delicha","sequence":"additional","affiliation":[]},{"given":"Harold","family":"Koendgen","sequence":"additional","affiliation":[]},{"given":"Ramin","family":"Farzaneh-Far","sequence":"additional","affiliation":[]},{"given":"Petra W","family":"Duda","sequence":"additional","affiliation":[]},{"given":"Camil","family":"Sayegh","sequence":"additional","affiliation":[]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[]},{"given":"Anthony A.","family":"Amato","sequence":"additional","affiliation":[]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[]},{"given":"Suur","family":"Biliciler","sequence":"additional","affiliation":[]},{"given":"Hector","family":"Chinoy","sequence":"additional","affiliation":[]},{"given":"Mazen M.","family":"Dimachkie","sequence":"additional","affiliation":[]},{"given":"Christyn","family":"Edmundson","sequence":"additional","affiliation":[]},{"given":"Miriam","family":"Freimer","sequence":"additional","affiliation":[]},{"given":"Anthony","family":"Geraci","sequence":"additional","affiliation":[]},{"given":"Yessar","family":"Hussain","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Machado","sequence":"additional","affiliation":[]},{"given":"Andrew L.","family":"Mammen","sequence":"additional","affiliation":[]},{"given":"Tahseen","family":"Mozaffar","sequence":"additional","affiliation":[]},{"given":"Payam","family":"Soltanzadeh","sequence":"additional","affiliation":[]},{"given":"Niraja","family":"Suresh","sequence":"additional","affiliation":[]},{"given":"Anneke","family":"van der Kooi","sequence":"additional","affiliation":[]},{"given":"Yves","family":"Allenbach","sequence":"additional","affiliation":[]},{"given":"Matthew","family":"Appleby","sequence":"additional","affiliation":[]},{"given":"Richard J","family":"Barohn","sequence":"additional","affiliation":[]},{"given":"Nicolas","family":"Champtiaux","sequence":"additional","affiliation":[]},{"given":"Christopher","family":"Doughty","sequence":"additional","affiliation":[]},{"given":"Jerrica","family":"Farias","sequence":"additional","affiliation":[]},{"given":"Constantine","family":"Farmakidis","sequence":"additional","affiliation":[]},{"given":"Ali A.","family":"Habib","sequence":"additional","affiliation":[]},{"given":"Chafic","family":"Karam","sequence":"additional","affiliation":[]},{"given":"James","family":"Lilleker","sequence":"additional","affiliation":[]},{"given":"Samantha","family":"Lorusso","sequence":"additional","affiliation":[]},{"given":"Mamatha","family":"Pasnoor","sequence":"additional","affiliation":[]},{"given":"Iago","family":"Pinal-Fernandez","sequence":"additional","affiliation":[]},{"given":"Giorgia","family":"Querin","sequence":"additional","affiliation":[]},{"given":"Joost","family":"Raaphorst","sequence":"additional","affiliation":[]},{"given":"George","family":"Ransley","sequence":"additional","affiliation":[]},{"given":"Sami","family":"Saba","sequence":"additional","affiliation":[]},{"given":"Kazim","family":"Sheikh","sequence":"additional","affiliation":[]},{"given":"Andrew","family":"Snedden","sequence":"additional","affiliation":[]},{"given":"Jeffrey","family":"Statland","sequence":"additional","affiliation":[]},{"given":"Tuan","family":"Vu","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S2665-9913(23)00003-6_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, the Netherlands, 14\u201316 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/S2665-9913(23)00003-6_bib2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/BOR.0000000000000547","article-title":"Peculiar clinicopathological features of immune-mediated necrotizing myopathies","volume":"30","author":"Allenbach","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/S2665-9913(23)00003-6_bib3","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.30344","article-title":"Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy","volume":"63","author":"Benveniste","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2665-9913(23)00003-6_bib4","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1002\/art.34673","article-title":"Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"64","author":"Werner","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2665-9913(23)00003-6_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.autrev.2018.09.008","article-title":"Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy","volume":"18","author":"Anquetil","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/S2665-9913(23)00003-6_bib6","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1212\/WNL.0000000000004923","article-title":"Necrosis in anti-SRP+ and anti-HMGCR+myopathies: role of autoantibodies and complement","volume":"90","author":"Allenbach","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/S2665-9913(23)00003-6_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/annrheumdis-2018-213518","article-title":"In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy","volume":"78","author":"Bergua","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S2665-9913(23)00003-6_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10082036","article-title":"Prevention of anti-HMGCR immune-mediated necrotising myopathy by C5 complement inhibition in a humanised mouse model","volume":"10","author":"Julien","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/S2665-9913(23)00003-6_bib9","unstructured":"Johnston J, Ricardo A, Arata M, et al. A phase 1 multiple-dose clinical study of RA101495, a subcutaneously administered synthetic macrocyclic peptide inhibitor of complement C5 for treatment of paroxysmal nocturnal hemoglobinuria. 21st Congress of the European Hematology Association; June 9\u201316, 2016 (LB2249)."},{"key":"10.1016\/S2665-9913(23)00003-6_bib10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamaneurol.2019.5125","article-title":"Clinical effects of the self-administered subcutaneous complement inhibitor zilucoplan in patients with moderate to severe generalized myasthenia gravis: results of a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial","volume":"77","author":"Howard","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/S2665-9913(23)00003-6_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/13543784.2021.1897567","article-title":"Zilucoplan: an investigational complement C5 inhibitor for the treatment of acetylcholine receptor autoantibody-positive generalized myasthenia gravis","volume":"30","author":"Howard","year":"2021","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/S2665-9913(23)00003-6_bib12","first-page":"s137","article-title":"Quality of life outcomes in RAISE: a double-blind randomized, placebo-controlled study of zilucoplan in gMG","volume":"66","author":"Weiss","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/S2665-9913(23)00003-6_bib13","first-page":"s108","article-title":"Efficacy and safety of zilucoplan in myasthenia gravis: responder analysis from the randomized phase 3 RAISE trial","volume":"66","author":"Vu","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/S2665-9913(23)00003-6_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-018-0732-6","article-title":"Immune-mediated necrotizing myopathy","volume":"20","author":"Pinal-Fernandez","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/S2665-9913(23)00003-6_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MD.0000000000000028","article-title":"Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin","volume":"93","author":"Allenbach","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/S2665-9913(23)00003-6_bib16","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1097\/RHU.0000000000001786","article-title":"Role of intravenous immunoglobulin in necrotizing autoimmune myopathy","volume":"28","author":"Kocoloski","year":"2022","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/S2665-9913(23)00003-6_bib17","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1093\/rheumatology\/keac014","article-title":"Outcome predictors of immune-mediated necrotizing myopathy- a retrospective, multicentre study","volume":"61","author":"Wang","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/S2665-9913(23)00003-6_bib18","series-title":"Muscles, testing and function: with posture and pain","author":"Kendall","year":"1993"},{"key":"10.1016\/S2665-9913(23)00003-6_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01936","article-title":"Clinical and genetic spectrum of a large cohort with total and sub-total complement deficiencies","volume":"10","author":"El Sissy","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/S2665-9913(23)00003-6_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.15790","article-title":"Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis","volume":"185","author":"Soci\u00e9","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/S2665-9913(23)00003-6_bib21","article-title":"Measuring the 50% haemolytic complement (CH50) activity of serum","volume":"37","author":"Costabile","year":"2010","journal-title":"J Vis Exp"},{"issue":"suppl 1","key":"10.1016\/S2665-9913(23)00003-6_bib22","first-page":"1","article-title":"Abstracts of the 6th Congress of the European Academy of Neurology, virtual 2020","volume":"27","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/S2665-9913(23)00003-6_bib23","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ana.24902","article-title":"Pathogenic role of anti-signal recognition protein and anti-3-hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies","volume":"81","author":"Arouche-Delaperche","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/S2665-9913(23)00003-6_bib24","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/art.40064","volume":"69","author":"Aggarwal","year":"2017","journal-title":"Arthritis Rheumatol"}],"container-title":["The Lancet Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665991323000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665991323000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T10:11:21Z","timestamp":1762942281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2665991323000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2665991323000036"],"URL":"https:\/\/doi.org\/10.1016\/s2665-9913(23)00003-6","relation":{},"ISSN":["2665-9913"],"issn-type":[{"value":"2665-9913","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2665-9913(23)00003-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2665-9913(23)00002-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}